Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV000996928 | SCV001151927 | uncertain significance | not provided | 2019-02-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000996928 | SCV001767947 | uncertain significance | not provided | 2024-05-24 | criteria provided, single submitter | clinical testing | In silico analysis indicates that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Labcorp Genetics |
RCV000996928 | SCV002310450 | uncertain significance | not provided | 2024-01-29 | criteria provided, single submitter | clinical testing | This sequence change replaces glutamic acid, which is acidic and polar, with glutamine, which is neutral and polar, at codon 756 of the LTBP4 protein (p.Glu756Gln). This variant is present in population databases (rs199691160, gnomAD 0.2%). This variant has not been reported in the literature in individuals affected with LTBP4-related conditions. ClinVar contains an entry for this variant (Variation ID: 808585). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Fulgent Genetics, |
RCV002497305 | SCV002779459 | uncertain significance | Cutis laxa with severe pulmonary, gastrointestinal and urinary anomalies | 2022-02-14 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003235442 | SCV003933723 | uncertain significance | not specified | 2023-05-05 | criteria provided, single submitter | clinical testing |